SCHEMBL5804285

SCHEMBL5804285

CCOC(=O)c1c(-c2ccc(OC)c(OC)c2)csc1NC(=O)CS

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.72
ALDH1A1 P00352 9/20 0.64
HTT P42858 4/20 0.64
CRHBP P24387 1/20 0.64
CRHR2 Q13324 1/20 0.64
LMNA P02545 5/20 0.59
HPGD P15428 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
NPSR1 Q6W5P4 2/20 0.59
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2C9 P11712 2/20 0.58
CYP2C19 P33261 2/20 0.58
KDM4E B2RXH2 1/20 0.58
POLB P06746 1/20 0.55
RAB9A P51151 1/20 0.55
NPC1 O15118 1/20 0.54
PTPN1 P18031 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804278 0.91 MAPT (0.73) MAPTALDH1A1HTTCRHBPCRHR2
SCHEMBL13837645 0.88 MAPT (0.76) MAPTALDH1A1HTTCRHBPCRHR2
SCHEMBL5807228 0.86 LMNA (0.70) MAPTALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL8290370 0.83 MAPT (0.68) MAPTALDH1A1HTTCRHBPCRHR2
SCHEMBL5804336 0.82 POLB (0.74) MAPTALDH1A1HTTLMNAHPGD
SCHEMBL8288763 0.80 MAPT (0.64) MAPTALDH1A1HTTCRHBPCRHR2
SCHEMBL8288714 0.79 PRKCZ (0.81) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL5807226 0.76 LMNA (0.71) MAPTALDH1A1HTTLMNAHPGD
SCHEMBL5804332 0.73 POLB (0.74) MAPTALDH1A1HTTLMNAHPGD
SCHEMBL14478927 0.73 TP53 (0.65) MAPTALDH1A1HTTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006093518-A2 THIENYL COMPOUNDS FOR TREATING VIRUS-RELATED CONDITIONS APATH, LLC (US) 2006-09-08 WO disclosed